共 50 条
- [1] COMBINATION OF BEVACIZUMAB AND IRINOTECAN FOR RECURRENT MALIGNANT GLIOMAS: A RETROSPECTIVE STUDY OF EFFICACY AND SAFETYNEURO-ONCOLOGY, 2008, 10 (06) : 1096 - 1096Martinez Garcia, M.论文数: 0 引用数: 0 h-index: 0机构: Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, Spain Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, SpainReynes, G.论文数: 0 引用数: 0 h-index: 0机构: H La Fe, Valencia, Spain Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, SpainBalana, C.论文数: 0 引用数: 0 h-index: 0机构: Inst Catalan Oncol H German Trias & Pujol, Badalona, Spain Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, SpainFernandez Chacon, C.论文数: 0 引用数: 0 h-index: 0机构: MDMAnderson, Madrid, Spain Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, SpainBenavides, M.论文数: 0 引用数: 0 h-index: 0机构: H Carlos Haya, Malaga, Spain Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, SpainPerez Segura, P.论文数: 0 引用数: 0 h-index: 0机构: H Clin San Carlos, Madrid, Spain Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, SpainHerrero, A.论文数: 0 引用数: 0 h-index: 0机构: H Miguel Servet, Zaragoza, Spain Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, SpainGarcia Velasco, A.论文数: 0 引用数: 0 h-index: 0机构: Inst Catalan Oncol H Trueta, Girona, Spain Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, SpainPerez Martin, X.论文数: 0 引用数: 0 h-index: 0机构: Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, Spain Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, SpainGil Gil, M.论文数: 0 引用数: 0 h-index: 0机构: Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, Spain Inst Catalan Oncol H Duran & Reynals, Lhospitalet De Llobregat, Spain
- [2] BEVACIZUMAB PLUS FOTEMUSTINE COMBINATION: ACTIVITY AND SAFETY IN RECURRENT MALIGNANT GLIOMASNEURO-ONCOLOGY, 2012, 14 : 51 - 52Vaccaro, V.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Inst Regina Elena, Rome, Italy Natl Canc Inst Regina Elena, Rome, ItalyPace, A.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Inst Regina Elena, Rome, Italy Natl Canc Inst Regina Elena, Rome, ItalyVidiri, A.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Inst Regina Elena, Rome, Italy Natl Canc Inst Regina Elena, Rome, ItalyVari, S.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Inst Regina Elena, Rome, Italy Natl Canc Inst Regina Elena, Rome, ItalyTelera, S.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Inst Regina Elena, Rome, Italy Natl Canc Inst Regina Elena, Rome, ItalyGiannarelli, D.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Inst Regina Elena, Rome, Italy Natl Canc Inst Regina Elena, Rome, ItalyRussillo, M.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Inst Regina Elena, Rome, Italy Natl Canc Inst Regina Elena, Rome, ItalyAnelli, V.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Inst Regina Elena, Rome, Italy Natl Canc Inst Regina Elena, Rome, ItalyCarapella, C. M.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Inst Regina Elena, Rome, Italy Natl Canc Inst Regina Elena, Rome, ItalyFabi, A.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Inst Regina Elena, Rome, Italy Natl Canc Inst Regina Elena, Rome, Italy
- [3] Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant GliomasCLINICAL CANCER RESEARCH, 2008, 14 (21) : 7068 - 7073Desjardins, Annick论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USA Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USAReardon, David A.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USAHerndon, James E., II论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USAMarcello, Jennifer论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USAQuinn, JenniferA.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USARich, Jeremy N.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USASathornsumetee, Sith论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USAGururangan, Sriclharan论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USASampson, John论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USABailey, Leighann论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USABigner, Darell D.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USAFriedman, Allan H.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USAFriedman, Henry S.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USAVredenburgh, James J.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Surg, Durham, NC 27710 USA
- [4] Retrospective analysis to evaluate the efficacy and the safety of Bevacizumab in the treatment of recurrent malignant gliomasTranslational Medicine Communications, 3 (1)Arsela Prelaj论文数: 0 引用数: 0 h-index: 0机构: “Sapienza” University of Rome,Department of Radiological, Oncological and AnatomoSara Elena Rebuzzi论文数: 0 引用数: 0 h-index: 0机构: “Sapienza” University of Rome,Department of Radiological, Oncological and AnatomoMaurizio Salvati论文数: 0 引用数: 0 h-index: 0机构: “Sapienza” University of Rome,Department of Radiological, Oncological and AnatomoSilvia Pecorari论文数: 0 引用数: 0 h-index: 0机构: “Sapienza” University of Rome,Department of Radiological, Oncological and AnatomoChiara Pozzi论文数: 0 引用数: 0 h-index: 0机构: “Sapienza” University of Rome,Department of Radiological, Oncological and AnatomoCarmela Fusto论文数: 0 引用数: 0 h-index: 0机构: “Sapienza” University of Rome,Department of Radiological, Oncological and AnatomoCarla Ferrara论文数: 0 引用数: 0 h-index: 0机构: “Sapienza” University of Rome,Department of Radiological, Oncological and AnatomoSilverio Tomao论文数: 0 引用数: 0 h-index: 0机构: “Sapienza” University of Rome,Department of Radiological, Oncological and AnatomoVincenzo Bianco论文数: 0 引用数: 0 h-index: 0机构: “Sapienza” University of Rome,Department of Radiological, Oncological and Anatomo
- [5] Bevacizumab and irinotecan in the treatment of recurrent malignant gliomasCANCER JOURNAL, 2008, 14 (05): : 279 - 285de Groot, John F.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Unit 431, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Unit 431, Houston, TX 77030 USAYung, Wai Kwan A. Fred论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Unit 431, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Unit 431, Houston, TX 77030 USA
- [6] Activity and Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant GliomasBIOMED RESEARCH INTERNATIONAL, 2014, 2014Vaccaro, V.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyFabi, A.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyVidiri, A.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Diagnost Oncol Dept, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyGiannarelli, D.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Biostat Unit, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyMetro, G.论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Perugia, Santa Maria Misericordia Hosp, Div Med Oncol, Perugia, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyTelera, S.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Div Neurosurg, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyVari, S.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyPiludu, F.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Diagnost Oncol Dept, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyCarosi, M. A.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Dept Pathol, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyVillani, V.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Div Neurol, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyCognetti, F.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyPompili, A.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Div Neurosurg, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyMarucci, L.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Dept Radiat Oncol, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyCarapella, C. M.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Div Neurosurg, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, ItalyPace, A.论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Div Neurol, I-00144 Rome, Italy Regina Elena Inst Canc Res, Dept Med Oncol, I-00144 Rome, Italy
- [7] Bevacizumab plus irinotecan in patients with recurrent high grade malignant gliomas.JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Legaspi, Jairo论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainCeniceros, Lucia论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainEspinos, Jaime论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainValtuena, German论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainMartin, Patricia论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainCastanon Alvarez, Eduardo论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainAristu, Javier论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainBaraibar, Iosune论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainSalas, Diego论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainSala, Pablo论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainGardeazabal, Itziar论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainZubiri Oteiza, Leyre论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainOlarte, Alicia论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainGil-Bazo, Ignacio论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainDominguez, Pablo论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainPablo Fusco, Juan论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainIsabel Martinez, Maria论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainAramendia, Jose M.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainFernandez-Hidalgo, Oscar论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, SpainSantisteban, Marta论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Pamplona, Spain
- [8] ACTIVITY AND SAFETY OF THE COMBINATION BEVACIZUMAB AND FOTEMUSTINE IN RECURRENT MALIGNANT GLIOMASNEURO-ONCOLOGY, 2013, 15 : 108 - 108Fabi, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Rome, Italy Regina Elena Inst Canc Res, Rome, ItalyVillani, Veronica论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Rome, Italy Regina Elena Inst Canc Res, Rome, ItalyVaccaro, Vanja论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Rome, Italy Regina Elena Inst Canc Res, Rome, ItalyVidiri, Antonello论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Rome, Italy Regina Elena Inst Canc Res, Rome, ItalyGiannarelli, Diana论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Rome, Italy Regina Elena Inst Canc Res, Rome, ItalyPiludu, Francesca论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Rome, Italy Regina Elena Inst Canc Res, Rome, ItalyAnelli, Vincenzo论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Rome, Italy Regina Elena Inst Canc Res, Rome, ItalyCarapella, Carmine论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Rome, Italy Regina Elena Inst Canc Res, Rome, ItalyCognetti, Francesco论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Rome, Italy Regina Elena Inst Canc Res, Rome, ItalyPace, Andandrea论文数: 0 引用数: 0 h-index: 0机构: Regina Elena Inst Canc Res, Rome, Italy Regina Elena Inst Canc Res, Rome, Italy
- [9] BEVACIZUMAB (BV) PLUS IRINOTECAN IN RECURRENT MALIGNANT GLIOMA (MG) SHOWED HIGH OVERALL SURVIVAL (OS) IN A RETROSPECTIVE STUDYNEURO-ONCOLOGY, 2010, 12 : 53 - 53Gil, Miguel J.论文数: 0 引用数: 0 h-index: 0机构: Inst Catala Oncol, Badalona, Spain Inst Catala Oncol, Badalona, Spainde las Penas, Ramon论文数: 0 引用数: 0 h-index: 0机构: Inst Catala Oncol, Badalona, SpainReynes, Gaspar论文数: 0 引用数: 0 h-index: 0机构: Hosp La Fe Valencia, Valencia, Spain Inst Catala Oncol, Badalona, SpainBalana, Carmen论文数: 0 引用数: 0 h-index: 0机构: Inst Catala Oncol, Badalona, Spain Inst Catala Oncol, Badalona, SpainPerez-Segura, Pedro论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin San Carlos, Madrid, Spain Inst Catala Oncol, Badalona, SpainGarcia-Velasco, Adelaida论文数: 0 引用数: 0 h-index: 0机构: Inst Catala Oncol, Girona, Spain Inst Catala Oncol, Badalona, SpainGallego, Oscar论文数: 0 引用数: 0 h-index: 0机构: Hosp Santa Creu & Sant Pau, Barcelona, Spain Inst Catala Oncol, Badalona, SpainHerrero, Ana论文数: 0 引用数: 0 h-index: 0机构: Hosp Miguel Servet, Zaragoza, Spain Inst Catala Oncol, Badalona, SpainFernandez-Chacon de Lucas, Concepcion论文数: 0 引用数: 0 h-index: 0机构: MDAndeson, Madrid, Spain Inst Catala Oncol, Badalona, SpainBenavides, Manual论文数: 0 引用数: 0 h-index: 0机构: Hosp Carlos Haya, Malaga, Spain Inst Catala Oncol, Badalona, SpainPerez-Martin, Xavier论文数: 0 引用数: 0 h-index: 0机构: Inst Catala Oncol, Badalona, Spain Inst Catala Oncol, Badalona, SpainMesia, Carlos论文数: 0 引用数: 0 h-index: 0机构: Inst Catala Oncol, Badalona, Spain Inst Catala Oncol, Badalona, SpainMartinez-Garcia, Maria论文数: 0 引用数: 0 h-index: 0机构: Hosp del Mar, Barcelona, Spain Inst Catala Oncol, Badalona, Spain
- [10] EFFICACY OF BEVACIZUMAB PLUS IRINOTECAN IN CHILDREN WITH RECURRENT OR PROGRESSIVE MALIGNANT GLIOMANEURO-ONCOLOGY, 2014, 16 : 59 - 59Arakawa, Yoshiki论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, JapanUmeda, Katsutsugu论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, JapanWatanabe, Ken-ichiro论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, JapanMizowaki, Takashi论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, JapanHiraoka, Masahiro论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan论文数: 引用数: h-index:机构:Adachi, Souichi论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, JapanKunieda, Takeharu论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, JapanTakagi, Yasushi论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, JapanMiyamoto, Susumu论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan